← Back to Search
BP-C1 In Treatment Of Patients With Stage IV Breast Cancer: A Randomized, Double-blind, Placebo-controlled Multicenter Study And Additional Open-label Treatment Phase.
S. Larsén, A. Manikhas, E. Trishkina, M. Matrosova, Elena Poddubuskaya, S. Jensen
Published 2015 · Medicine
Download PDFAnalyze on Scholarcy
e12086 Background: The aims were to compare the efficacy and tolerability of a new benzene-poly-carboxylic acids complex with cis-diammineplatium (II) (BP-C1) versus equal looking placebo and to in...
This paper references
Panel on Handling Missing Data in Clinical Trials and Committee on National Statistics, editor
Breast Liver Metastases – Incidence, Diagnosis and Outcome
A. L. Hoe (1991)
Liposomal Doxorubicin in the Treatment of Breast Cancer Patients: A Review
J. Lao (2013)
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
A. Goldhirsch (2009)
Disease-free survival after resection of lung metastases in patients with breast cancer.
C. Ludwig (2003)
Treatment and outcome of brain metastasis as first site of distant metastasis from breast cancer
W. Boogerd (2004)
Continuous 5-fluorouracil in the treatment of breast cancer.
D. Cameron (1994)
Last observation carry-forward and last observation analysis.
J. Shao (2003)
TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.
L. Carey (2012)
The curability of breast cancer and the treatment of advanced disease
V. Guarneri (2004)
Cisplatin as first-line therapy for metastatic breast cancer.
G. Sledge (1988)
Phase II study of neoadjuvant pegylated liposomal doxorubicin and cyclophosphamide ± trastuzumab followed by docetaxel in locally advanced breast cancer
M. Tuxen (2014)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Early Breast Cancer Trialists' Collaborative Group (2005)
Patients with breast cancer are treated at home
L. Poulsen (2014)
Using Multivariate Statistics
B. Tabachnick (1983)
Capecitabine monotherapy: safe and effective treatment for metastatic breast cancer.
W. Ershler (2006)
Benzene-Poly-Carboxylic Acid Complex, a Novel Anti-Cancer Agent Induces Apoptosis in Human Breast Cancer Cells
F. Fares (2014)
Overview of resistance to systemic therapy in patients with breast cancer.
A. González-Angulo (2007)
Interaction of 3H-Labeled Benzene-Polycarboxylic Acids (BP-Cx-1) with Tumours and Normal Cell Cultures
IV Perminova (2012)
Loratadine and terfenadine in perennial allergic rhinitis
K. Carlsen (1993)
Cancer Statistics, 2010
A. Jemal (2010)
Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial
A. Miller (2014)
Categorical Data Analysis.
D. Lendrem (1991)
Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).
L. Shulman (2014)
Panel members. Threshold for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer
A Goldhirsch (2009)
PAM50 breast cancer intrinsic subtypes and effect of gemcitabine in advanced breast cancer patients
C. Jørgensen (2014)
Improvement of survival and prospect of cure in patients with metastatic breast cancer
Y. Cheng (2011)
Monotherapy of metastatic breast cancer: a review of newer agents.
C. Vogel (1999)
Benzene-Poly-Carboxylic Acids Complex with Cis-Diammineplatinum (II) Dichloride in the Treatment of Stage IV Breast Cancer Patients
S. Dewi (2013)
Clinical Trials: A Practical Approach
S. Pocock (1984)
Practical statistics for medical research
D. Altman (1990)